Ξ Marcelo D.

Making extinction a thing of the past. Colossal is a breakthrough bioscience and genetic engineering company that builds radical new technologies to advance the field of genomics. Colossal creates disruptive technologies for extinct species restoration, critically endangered species protection and the repopulation of critical ecosystems that support the continuation of life on Earth. The company is the first to apply CRISPR technology for the purposes of species de-extinction. Colossal is accepting humanity’s duty to restore Earth to a healthier state, while also solving for the future economies and biological necessities of the human condition through cutting-edge science and technologies.

The Proof of Attendance Protocol turns precious moments into collectibles. Using blockchain technology, POAP tokenizes your memories, so they can last forever and be truly yours. Making memories durable has deep implications for how people organize. From entertainment, to direct funding, to fostering belonging, were building a better world with POAP.

MovieBot (formerly Teleportal) is an app for creating 3D animated video using cutting edge AI technology. Simply type your story topic, sit back, and enjoy as MovieBot brings your story to life. For advanced creators, every MovieBot video is fully editable and can be customized using performance capture based animation. MovieBot is available on iOS and Android.

BRELYON is a deep tech, venture-backed Silicon Valley-based startup that is introducing a new category of immersive displays to bring metaverse on to your desk. We post on topics about metaverse, computer graphics, gaming industry, AR, VR, lightfield displays and 3D displays. Join the community!

Aegis Life, Inc. is a biotechnology company founded in early 2020 with a mission to prevent and treat existing, emerging, and future contagions. Our nucleic acid delivery technology Fusogenix PLV stems from more than a decade of research and development in gene delivery. We actively leverage the Fusogenix PLV platform to accelerate the discovery, clinical development, and manufacture of vaccines and therapeutics for infectious diseases.

Axiom Space is a human space exploration company, building era-defining space infrastructure and delivering technology-driven solutions that will empower civilization to transcend Earth. Beginning with Axiom Station, successor to the International Space Station, the company is pioneering a next-generation orbital settlement that will foster groundbreaking innovation and research in microgravity and drive the global space economy of tomorrow. Today, guided by the vision of leading humanitys expansion off planet, Axiom Space is the principal provider of commercial human spaceflight services and developer of advanced spacesuits for the Moon and beyond. Connect with us: instagram.com/axiom.space/ twitter.com/axiom_space facebook.com/axiomspace/ youtube.com/axiomspace

A rocket company at the core, Relativity Space is on a mission to become the next great commercial launch company. With an ever-growing need for space infrastructure, demand for launch services is continuously outpacing supply. Our reusable rockets can meet this demand, offering customers the right size payload capacity at the right cost. Leveraging advances in additive manufacturing, we are strategically focused on reducing vehicle complexity, cost, and time to market. Our patented technologies enable innovative designs once thought impossible and unlock new value propositions in the booming space economy.

Mojo Vision is focused on developing and commercializing high-performance micro-LED display technology for consumer, enterprise, and government applications. The company combines breakthrough technology, leading display and semiconductor expertise, and an advanced 300mm manufacturing process to deliver on the promise of micro-LED displays. Mojo’s proprietary quantum-dot technology brings full color capability to its display platform and meets the superior performance demands for all form factors. Mojo Vision developed the world’s smallest, densest dynamic display for the first AR smart contact lens and is now applying this innovation and expertise to lead the disruption of the $160 billion display industry.

Excision BioTherapeutics is a private company focused on developing advanced gene editing therapeutics to address the medical need for the treatment of life-threatening disease caused by viral infections. Our mission is to advance gene editing therapeutics for our indications into safe and efficacious medicines that will greatly improve the lives of infected individuals around the world.

TransAstra is developing game-changing technologies in the areas of orbital logistics and space resources to enable massive growth to existing and entirely new space industries. These resources include water and other valuable materials to be found on asteroids and lunar poles. We lead the world in cislunar supply chain solutions to service commercial satellite manufacturers, space-tech makers, and the rapidly evolving space tourism market.

MAIA Biotechnology is a targeted therapy, immune-oncology company, focused on development and commercialization of first-in-class drugs with novel mechanisms of action that are intended to meaningfully improve and extend the lives of people with cancer. A publicly traded company based in Chicago, MAIA (NYSE American: MAIA) is led by a passionate, principled and highly experienced Management Team with significant drug development experience, committed to advancing promising agents into human clinical trials. MAIA’s business strategy is designed to advance a strong value proposition for its portfolio of potentially novel compounds. MAIA controls risk and enhances its opportunity for success by diversifying and generating this portfolio of assets with a variety of compounds with novel mechanisms of action which have potential activity in multiple tumor types. MAIA’s business model involves placing drug candidates in their own dedicated, R&D focused subsidiary company, which is supported by the common infrastructure, management team, and resources of the MAIA enterprise. This model allows MAIA to provide more focused R&D support to each drug candidate, while also distributing shared central resources among subsidiary companies to maintain a lean, capital-efficient operating structure.

We are a leading Web3-native investment manager with focus on fostering dynamic blockchain ecosystems & dedicated to help founders achieve their full potential.

We are the builders of Algorand, the high performance Layer-1 blockchain. Let us unlock the power of Algorand for you.

Synthetix is a derivatives liquidity protocol providing the backbone for derivatives trading in DeFi.

Arweave uberizes the traditional web hosting environment, connecting people with spare hard drive space with people that need web hosting. This system offers unparalleled levels of data replication and security for users, as well as financial incentives for participants in the network. Arweave has set the new standard of highly reliable, lightning fast web application hosting at a fraction of the cost of traditional centralised providers. In April 2018, Arweave graduated from the mentorship-driven startup acceleration program at Techstars Berlin. After raising $8.7 million through token sales, Arweave launched its mainnet in June 2018. In January 2019, we launched the permaweb, a permanent serverless web built on top of the Arweave. This is the web you can own and run. Visit our website to learn how you can use Arweave to deploy web apps, archive web pages, mine and much more!

Making extinction a thing of the past. Colossal is a breakthrough bioscience and genetic engineering company that builds radical new technologies to advance the field of genomics. Colossal creates disruptive technologies for extinct species restoration, critically endangered species protection and the repopulation of critical ecosystems that support the continuation of life on Earth. The company is the first to apply CRISPR technology for the purposes of species de-extinction. Colossal is accepting humanity’s duty to restore Earth to a healthier state, while also solving for the future economies and biological necessities of the human condition through cutting-edge science and technologies.

The Proof of Attendance Protocol turns precious moments into collectibles. Using blockchain technology, POAP tokenizes your memories, so they can last forever and be truly yours. Making memories durable has deep implications for how people organize. From entertainment, to direct funding, to fostering belonging, were building a better world with POAP.

MovieBot (formerly Teleportal) is an app for creating 3D animated video using cutting edge AI technology. Simply type your story topic, sit back, and enjoy as MovieBot brings your story to life. For advanced creators, every MovieBot video is fully editable and can be customized using performance capture based animation. MovieBot is available on iOS and Android.

BRELYON is a deep tech, venture-backed Silicon Valley-based startup that is introducing a new category of immersive displays to bring metaverse on to your desk. We post on topics about metaverse, computer graphics, gaming industry, AR, VR, lightfield displays and 3D displays. Join the community!

Aegis Life, Inc. is a biotechnology company founded in early 2020 with a mission to prevent and treat existing, emerging, and future contagions. Our nucleic acid delivery technology Fusogenix PLV stems from more than a decade of research and development in gene delivery. We actively leverage the Fusogenix PLV platform to accelerate the discovery, clinical development, and manufacture of vaccines and therapeutics for infectious diseases.